Singapore markets closed

Astellas Pharma Inc. (ALPMY)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
9.46-0.13 (-1.36%)
At close: 03:47PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in JPY. All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Cash flows from operating activities
Net income
4,198,000
98,714,000
124,086,000
120,589,000
195,411,000
Depreciation & amortisation
132,214,000
105,738,000
79,684,000
72,652,000
66,396,000
Change in working capital
-63,123,000
-24,209,000
5,956,000
-31,726,000
-43,792,000
Inventory
-54,346,000
-7,086,000
24,058,000
-2,318,000
-6,038,000
Other working capital
125,397,000
239,226,000
180,996,000
229,402,000
144,110,000
Other non-cash items
81,110,000
98,857,000
-17,839,000
38,116,000
-11,759,000
Net cash provided by operating activities
216,089,000
327,767,000
257,444,000
306,843,000
221,998,000
Cash flows from investing activities
Investments in property, plant and equipment
-90,692,000
-88,541,000
-76,448,000
-77,441,000
-77,888,000
Acquisitions, net
-784,784,000
0
-670,000
-14,916,000
-320,764,000
Sales/maturities of investments
456,000
12,624,000
5,576,000
-
-
Other investing activities
8,901,000
-13,353,000
-15,868,000
2,595,000
-127,000
Net cash used for investing activities
-846,363,000
-84,500,000
-62,413,000
-81,894,000
-389,793,000
Net change in cash
-127,838,000
60,854,000
-10,143,000
7,737,000
7,317,000
Cash at beginning of period
381,816,000
315,986,000
326,128,000
318,391,000
311,074,000
Cash at end of period
230,170,000
376,840,000
315,986,000
326,128,000
318,391,000
Free cash flow
Operating cash flow
216,089,000
327,767,000
257,444,000
306,843,000
221,998,000
Capital expenditure
-90,692,000
-88,541,000
-76,448,000
-77,441,000
-77,888,000
Free cash flow
125,397,000
239,226,000
180,996,000
229,402,000
144,110,000